Cytel Opens Office in Geneva - Extends Global Clinical Development Expertise

From the Wires

Nov. 29, 2012 10:41 AM

Cytel Inc., the leading provider of Clinical Research Services, today announced the opening of a new office in Geneva, Switzerland to support the growing demand for clinical research and biostatistical consulting capabilities throughout Europe. This office further expands Cytel’s global presence, which includes offices in Boston, Philadelphia, Providence, Paris, Pune, and Hyderabad.

“The opening of our Geneva office builds on our established business in Europe and allows us to support locally-based clients with an experienced team of Biostatisticians and Programmers. This team, all formerly with Merck Serono, brings considerable industry experience and therapeutic knowledge to Cytel’s Clinical Research Services business,” said Irving Dark, Vice President, Clinical Research Services. Sebastien Gerin, former Merck Serono SA Director and Global Head of Statistical Programming leads the team.

Cytel is a leader in the design and implementation of adaptive trials and offers robust Clinical Research Services capabilities including Data Management, Biostatistics and Programming, Medical Writing, CDISC Migration and Submission Support Services. Our Strategic Consulting group offers cutting edge study design and simulation, drug supply optimization, data visualization, and recruitment and endpoint forecasting. Cytel’s functional outsourcing business supports several major pharmaceutical and biotechnology customers from our two India based locations.

Cytel’s statistical software, East^®, Compass^®, SiZ^®, StatXact^®, and LogXact^® are industry standards. East is used by the 25 largest pharmaceutical companies and by international regulatory authorities. ACES^®, Cytel’s newest product, is being implemented by numerous sponsors to protect their trial integrity against bias and satisfying regulatory authorities.

Cytel Inc.

Our mission at Cytel is to improve success rates in the development of drugs, biologics and medical devices. We do this by improving the design and implementation of clinical trials through innovative application of statistical science, operations research, and new computational methods.

We are leaders in designing and deploying adaptive trials. All 25 leading biopharma companies rely on our technology in their clinical studies.

Published Nov. 29, 2012— Reads 148
Copyright © 2012 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.

About Business Wire
Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News

Are Legos the Building Blocks of the Cloud?

By David Honan

Legos have been a part of my life for as long as I can remember. Some of my earliest, fondest memories involve Legos - starting from a small car made from a couple of simple bricks to very complex spaceships and wild creatures. I’m always amazed at how nicely and cleanly they snap toge...

Big Data Will Revolutionize Learning

By Mark van Rijmenam

New technologies allow schools, colleges and universities to analyze absolutely everything that happens. From student behavior, testing results, career development of students as well as educational needs based on changing societies. A lot of this data has already been stored and is us...

Solving the Cloud Talent Gap

By Jeremy Geelan

A recent study by analyst firm IDC reports that in 2012, 1.7 million cloud computing-related roles across the globe could not be filled due to the lack of training, certification and experience in the applicant pool. As the global demand for cloud and big data expertise increases, empl...

Convergence and Interoperability Will Define Next-Gen Cloud Architectures

By Jeremy Geelan

Our more interconnected planet is accelerating the adoption and convergence of next-generation architectures, in the form of cloud, mobile and instrumented physical assets. Organizations that can effectively balance optimization and innovation, will be in a position to leverage new sys...

Achieving Scale and Performance in the Cloud

By Wiqar Chaudry

New breakthroughs in cloud-based data management empower databases with the necessary elasticity they need to be truly responsive to the ebbs and tides of supply and demand. Cloud computing allows all capital assets – computing power, memory and storage for example – to be exchanged a...